KNTE - KINNATE BIOPHARMA INC
This page shows which of the focused investors we track hold KNTE and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2023 it was held by 1 manager with an aggregate reported value of $4.31M, which is 0.00% of the combined portfolio.
As of Q4 2023, 1 tracked institutional manager held KNTE (KINNATE BIOPHARMA INC) with an aggregate reported value of $4.31M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades KNTE — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2023
- Ticker
- KNTE
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Viking Global Investors - Viking Global Investors | 0.02% | - | 1,820,462 | $4.31M |
Loading holder history for KNTE…